Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Keymed and Rona Partner to Discover siRNA Drugs for Severe Kidney Disease

publication date: May 17, 2023

Chengdu’s Keymed Biosciences partnered with Shanghai Rona Therapeutics to discover first-in-class siRNA therapeutics for severe kidney diseases, also known as Glomerulonephritis. Rona will use its proprietary RAZOR™ platform to discover and identify siRNA lead compounds aimed at a novel glomerulonephritis target, and Keymed will contribute biologic research and translational expertise. The collaboration will build on Rona's proprietary platform for RNAi targeting of liver and extrahepatic tissues. The two companies have signed a profit/loss agreement to develop and commercialize candidates from the collaboration, though details were not disclosed. More details....

Stock Symbol: (HK: 02162)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital